We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

998:HKEXChina CITIC Bank Corporation Ltd Class H Analysis

Data as of 2026-06-13 - not real-time

HK$110.20

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Alibaba (9988.HK) is trading well below its 20‑day (123.5) and 50‑day (127.4) moving averages, with a current price of 110.2, indicating a bearish technical backdrop. The 14‑day RSI of 33.8 suggests the stock is oversold, while a bearish MACD histogram reinforces downside momentum. Despite this, the consensus among 26 analysts is a strong‑buy with a mean target of 183.5, implying a perceived upside of over 60% from today’s level. However, the DCF‑derived fair value of only 43.5 HKD flags the market as overvalued relative to intrinsic fundamentals. On the fundamentals side, revenue growth is modest at 2.9% YoY, operating margins are thin (≈1%), and free cash flow is negative, raising concerns about the sustainability of the 0.93% dividend. The company carries a high debt‑to‑equity ratio of 25, and its beta of ~0.8 points to moderate systematic risk, while a 30‑day volatility of 47% signals price swings. Recent media attention from investor Michael Burry, who disclosed a new position in Alibaba, adds a short‑term sentiment boost but does not alter the underlying risk profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support at 106.1
  • Oversold RSI indicating potential bounce
  • Bearish MACD and high volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst consensus strong‑buy with 183 target
  • Potential earnings acceleration from cloud and international commerce
  • Current price provides a discount to analyst expectations

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt load and negative free cash flow
  • Ongoing regulatory scrutiny in China
  • Sustainable dividend unlikely without cash‑flow improvement

Key Metrics & Analysis

Financial Health

Revenue Growth2.90%
Profit Margin10.12%
P/E Ratio17.3
ROE9.22%
ROA2.12%
Debt/Equity25.01
P/B Ratio1.7
Op. Cash FlowHK$76.2B
Free Cash FlowHK$-44074250240

Technical Analysis

TrendBearish
RSI33.8
SupportHK$106.10
ResistanceHK$138.00
MA 20HK$123.50
MA 50HK$127.39
MA 200HK$145.12
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair ValueHK$43.53
Target PriceHK$183.48
Upside/Downside66.50%
GradeOvervalued
TypeValue
Dividend Yield0.93%

Risk Assessment

Beta0.83
Volatility47.04%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.